Circulating Tumor Cell PD-L1 Expression as Biomarker for Therapeutic Efficacy of Immune Checkpoint Inhibition in NSCLC
Vera Kloten(Bayer (Germany)), Thomas Schlange(Boehringer Ingelheim (Germany))
Cited by 99
Related Papers
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation
|Breast Cancer Research|2007|228